Skip to main content

Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis

Abstract

There has been increased interest in the role of anti-Proteus antibodies in the aetiology of rheumatoid arthritis (RA) and whether chemotherapeutic agents active against Proteus species might reduce the risk and/or exacerbations of RA. We examined the in vitro antibacterial effects of ten different silver preparations which were either ionic silver [Ag(I)] solutions or nanoparticulate silver (NPS) (Ag0) suspensions against ATCC and two wild (clinical) strains of Proteus. The data establish the low minimum inhibitory concentration and minimum bactericidal concentration of all the silver formulations tested against these four Proteus strains. In a pilot study, a potent NPS preparation ex vivo showed long-lasting anti-Proteus activity in a normal human volunteer.

This is a preview of subscription content, access via your institution.

References

  1. Chandler RW, Robinson H, Masi AT (1971) Serological investigations for evidence of an infectious aetiology of rheumatoid arthritis. Ann Rheum Dis 30:274–278

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  2. Cock I, van Vuuren SF (2013) Anti-Proteus activity of some South African medicinal plants: their potential for the prevention of rheumatoid arthritis. Inflammopharmacology. doi:10.1007/s10787-013-0179-3

    PubMed  Google Scholar 

  3. Cock I, Mohanty S, White A, Whitehouse M (2012) Colloidal silver (CS) as an antiseptic: two opposing viewpoints. Pharmacog Comm 2:47–56

    CAS  Article  Google Scholar 

  4. Dayanand S, Dayanand A, Sreedhar B, Dastager SG (2010) Antimicrobial activity of silver nanoparticles synthesized from novel Streptomyces species. Dig J Nanomater Bios 5:447–451

    Google Scholar 

  5. Deighton CM, Gray J, Bint AJ, Walker DJ (1992a) Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. Br J Rheumatol 31:241–245

    CAS  PubMed  Article  Google Scholar 

  6. Deighton CM, Gray SW, Bint AJ, Walker DJ (1992b) Specificity of the Proteus antibody response in rheumatoid arthritis. Ann Rheum Dis 51:1206–1207

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  7. Ebringer A (2012) Rheumatoid arthritis and Proteus. Springer, London, p 223

  8. Ebringer A, Rashid T, Wilson C (2003) Rheumatoid arthritis: proposal for the use of antimicrobial therapy in early cases. Scand J Rheumatol 32:2–11

    PubMed  Article  Google Scholar 

  9. Eckhardt S, Brunetto PS, Gagnon J, Prieve M, Geise B, Fromm KM (2013) Nanobio Silver: its interactions with peptides and bacteria, and its uses in medicine. Chem Rev 113:4708–4754

    CAS  PubMed  Article  Google Scholar 

  10. Fairley KF, Carson NE, Gutch RC, Leighton PO, Grounds AD, Laird EC et al (1971) Site of infection in acute urinary tract infection in general practice. Lancet 2:615

    CAS  PubMed  Article  Google Scholar 

  11. Ferrara P, Romaniello L, Vitelli O, Gatto A, Serva M, Cataldi L (2009) Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scand J Urol Nephrol 43:369–372

    PubMed  Article  Google Scholar 

  12. Kim JS, Kuk E, Yu KN, Kim J, Park SJ, Lee HJ et al (2007) Antimicrobial effects of silver nanoparticles. Nanomedicine 3:95–101

    CAS  PubMed  Article  Google Scholar 

  13. Laroo H (2013) Colloidal nanosilver—its production method, properties, standards, and its bio-efficacy as an inorganic antibiotic. J Phys Chem Biophys (Omicsonline.org ISSN: 2161-0398)

  14. Lee H, Ko KS, Song JH, Peck KR (2011) Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea. Microb Drug Resist 17:37–45

    CAS  PubMed  Article  Google Scholar 

  15. Liu J, Sonshine DA, Shervani S, Hurt RH (2010) Controlled release of biologically active silver from nanosilver surfaces. NANO 4:6903–6913

    CAS  Google Scholar 

  16. Lo B (2010) Ethical issues in clinical research: a practical guide. Walters Kluwer, Philadelphia, p 292

  17. Marambio-Jones C, Hoek EMV (2010) A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12:1531–1551

    CAS  Article  Google Scholar 

  18. O’Hara CM, Brenner FW, Miller JM (2000) Classification, identification and clinical significance of Proteus, Providencia and Morganella. Clin Microbiol Rev 13:534–546

    PubMed Central  PubMed  Article  Google Scholar 

  19. Rashid T, Ebringer A (2007) Rheumatoid arthritis is linked to Proteus—the evidence. Clin Rheumatol 26:1036–1043

    PubMed  Article  Google Scholar 

  20. Rashid T, Ebringer A (2011) Rheumatoid arthritis is caused by asymptomatic Proteus urinary tract infections. In: Nikibakhsh A (ed) Clinical management of complicated urinary tract infection. In-Tech. vol 11

  21. Rashid T, Tiwana H, Wilson C, Ebringer A (2001) Rheumatoid arthritis as an autoimmune disease caused by Proteus urinary tract infections: a proposal for a therapeutic protocol. Israeli Med Assoc J (IMAJ) 3:675–680

    CAS  Google Scholar 

  22. Senior BW, Anderson GA, Morley KD, Ma Kerr (1999) Evidence that patients with rheumatoid arthritis have asymptomatic ‘non-significant’ Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 8:99–106

    Article  Google Scholar 

  23. Sylver N (2009) Handbook of frequency therapy. Desert Gate, Phoenix, p 732

  24. Tiwana H, Wilson C, Cunningham P, Binder A, Ebringer A (1996) Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif. Br J Rheum 35:592–594

    CAS  Article  Google Scholar 

  25. Varner K, El-Badaway A, Feldhake D, Venkatapathy R (2010) State of the science literature review: everything nanosilver and more. US Environmental Protection Agency, Washington DC, p 363

  26. Whitehouse M, Butters D, Vernon-Roberts B (2013) Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (MyocrysinR) and metallic silver. Inflammopharmacology 21:291–300

    CAS  PubMed  Article  Google Scholar 

  27. Wilson C, Thakore D, Isenberg D, Ebringber A (1997) Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 16:187–189

    CAS  PubMed  Article  Google Scholar 

  28. Xiu Z-M, Zhang Q-B, Puppala HL, Colvin VL, Alvarez PJJ (2012) Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 12:4271–4275

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgments

We are indebted to A White and J Petty for advice and assistance with silver analyses; to M Baharevs (Sydney) and Academician V Nesterov (Omsk) for assistance and advice in using the MetAtron monitor; to Dr G Maas (USA) for providing Meso Silver; and to D Butters for preparing the final MS. The Brisbane Holland Park Lions Club and W Whitney (and friends) helped fund the NPS studies.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Michael Whitehouse.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Disaanayake, D.M.B.T., Faoagali, J., Laroo, H. et al. Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis. Inflammopharmacol 22, 73–77 (2014). https://doi.org/10.1007/s10787-013-0198-0

Download citation

Keywords

  • Proteus
  • Rheumatoid arthritis
  • Silver antimicrobials
  • Nanoparticulate silver